UnitedHealth Group stock holds near USD 373 after Q2 earnings

Published on 09/23/2026 at 12:23 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

UnitedHealth Group stock closed at USD 372.80 on September 22, 2026, 19.24 percent below its yearly high. Q2 revenue reached USD 112.03 billion.

Fotorealistisches Krankenhaus-Außengebäude bei Sonnenuntergang mit Glasfassade und Fußgängern — UnitedHealth Group US91324P1021 zeigt modernes Krankenhaus im Sonnenuntergang mit Glasfassade und Besuchern, Illustration mit AI erstellt.

UnitedHealth Group (ISIN US91324P1021) closed at USD 372.80 on the NYSE on September 22, 2026, down 1.26 percent from the previous session. The stock remained 19.24 percent below its 52-week high of USD 461.62, giving the latest price action a clear recovery test after the second-quarter earnings update.

Stock stays below yearly high

The latest market snapshot lists UnitedHealth Group at a previous close of USD 377.56, with an intraday range of USD 372.41 to USD 381.00 and volume of 4,485,262 shares as of September 23, 2026. The 52-week range stood at USD 255.97 to USD 461.62, while market capitalization was USD 334.758 billion.

For investors, the comparison with the yearly range matters more than the single-session move. The September 22 close was USD 88.82 below the yearly high and USD 116.80 above the yearly low of USD 256.00 recorded on March 28, 2026. UnitedHealth Group therefore traded materially above its annual low while still below its July peak.

Q2 revenue reaches USD 112.03 billion

UnitedHealth Group reported second-quarter 2026 revenue of USD 112.03 billion, compared with analyst expectations of USD 110.81 billion, according to MarketBeat on September 22, 2026. Revenue was up 0.4 percent from the same quarter of the previous year.

Adjusted earnings per share reached USD 6.38 in Q2 2026, versus consensus of USD 4.94 and USD 4.08 in the year-earlier quarter, according to MarketBeat. The USD 1.44 EPS gap versus consensus is the central quantified support for the current earnings narrative, although the stock price remained below its 52-week high.

The same September 22 report states that UnitedHealth Group set fiscal-year 2026 adjusted EPS guidance at USD 19.50 to USD 20.00. MarketBeat also reported an average analyst rating of Moderate Buy and an average price target of USD 456.56, but that consensus figure does not remove the gap between the current price and the upper end of the annual range.

USD 372.80 remains the reference price

UnitedHealth Group stock closed at USD 372.80 on the NYSE on September 22, 2026, with the daily change measured at minus 1.26 percent against the prior close. The next market checkpoint is whether the Q2 earnings improvement, including the USD 6.38 EPS result and the USD 19.50 to USD 20.00 fiscal-year guidance range, can support a move back toward the yearly high.